Molecular targets for suppression of metastasis: Recent cellular observations

Siro Simizu, Yuki Niwa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cancer metastasis is regulated by many factors. In this review article, we introduce novel molecular targets for the suppression of cancer metastasis. Dehydroxymethylepoxyquinomicin (DHMEQ) is a specific inhibitor of NF-κB that inhibits many types of cancer cell growth in vivo. Recently, DHMEQ was reported to suppress cell invasion in an ovarian cancer cell line due to the deregulation of the autocrine system of CXCL12/ CXCR4. An ATP-sensitive K + channel blocker, glybenclamide, has been reported to suppress PDGF secretion, thereby inhibiting cell migration in ovarian cancer. Other emerging molecular targets are glycosaminoglycan (GAG)-degrading enzymes, such as heparanase and hyaluronidases. These inhibitors have been shown to suppress cancer cell metastasis both in vitro and in vivo. We previously reported the important role of protein glycosylation for metastasis-related protein functions. Thus, we hypothesize that NF-κB, K+ channels, GAG-degrading enzymes, and protein glycosylation may be useful targets for suppression of metastasis.

Original languageEnglish
Pages (from-to)43-51
Number of pages9
JournalForum on Immunopathological Diseases and Therapeutics
Volume4
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Glycosylation
Neoplasm Metastasis
Glycosaminoglycans
Cells
Proteins
Hyaluronoglucosaminidase
Deregulation
Glyburide
Ovarian Neoplasms
Cell growth
Enzymes
Neoplasms
Adenosine Triphosphate
Cell Movement
Cell Line
Growth
dehydroxymethylepoxyquinomicin
heparanase

Keywords

  • CXCL12/CXCR4
  • Glycosylation
  • Heparanase
  • Invasion
  • K channel
  • Metastasis
  • Migration
  • Molecular target
  • Nuclear factor κB (NF-κB)

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Biochemistry
  • Biotechnology

Cite this

Molecular targets for suppression of metastasis : Recent cellular observations. / Simizu, Siro; Niwa, Yuki.

In: Forum on Immunopathological Diseases and Therapeutics, Vol. 4, No. 1, 2013, p. 43-51.

Research output: Contribution to journalArticle

@article{f747d41d1e9441f6bf46005657e3c84b,
title = "Molecular targets for suppression of metastasis: Recent cellular observations",
abstract = "Cancer metastasis is regulated by many factors. In this review article, we introduce novel molecular targets for the suppression of cancer metastasis. Dehydroxymethylepoxyquinomicin (DHMEQ) is a specific inhibitor of NF-κB that inhibits many types of cancer cell growth in vivo. Recently, DHMEQ was reported to suppress cell invasion in an ovarian cancer cell line due to the deregulation of the autocrine system of CXCL12/ CXCR4. An ATP-sensitive K + channel blocker, glybenclamide, has been reported to suppress PDGF secretion, thereby inhibiting cell migration in ovarian cancer. Other emerging molecular targets are glycosaminoglycan (GAG)-degrading enzymes, such as heparanase and hyaluronidases. These inhibitors have been shown to suppress cancer cell metastasis both in vitro and in vivo. We previously reported the important role of protein glycosylation for metastasis-related protein functions. Thus, we hypothesize that NF-κB, K+ channels, GAG-degrading enzymes, and protein glycosylation may be useful targets for suppression of metastasis.",
keywords = "CXCL12/CXCR4, Glycosylation, Heparanase, Invasion, K channel, Metastasis, Migration, Molecular target, Nuclear factor κB (NF-κB)",
author = "Siro Simizu and Yuki Niwa",
year = "2013",
doi = "10.1615/ForumImmunDisTher.2013008306",
language = "English",
volume = "4",
pages = "43--51",
journal = "Forum on Immunopathological Diseases and Therapeutics",
issn = "2151-8017",
publisher = "Begell House Inc.",
number = "1",

}

TY - JOUR

T1 - Molecular targets for suppression of metastasis

T2 - Recent cellular observations

AU - Simizu, Siro

AU - Niwa, Yuki

PY - 2013

Y1 - 2013

N2 - Cancer metastasis is regulated by many factors. In this review article, we introduce novel molecular targets for the suppression of cancer metastasis. Dehydroxymethylepoxyquinomicin (DHMEQ) is a specific inhibitor of NF-κB that inhibits many types of cancer cell growth in vivo. Recently, DHMEQ was reported to suppress cell invasion in an ovarian cancer cell line due to the deregulation of the autocrine system of CXCL12/ CXCR4. An ATP-sensitive K + channel blocker, glybenclamide, has been reported to suppress PDGF secretion, thereby inhibiting cell migration in ovarian cancer. Other emerging molecular targets are glycosaminoglycan (GAG)-degrading enzymes, such as heparanase and hyaluronidases. These inhibitors have been shown to suppress cancer cell metastasis both in vitro and in vivo. We previously reported the important role of protein glycosylation for metastasis-related protein functions. Thus, we hypothesize that NF-κB, K+ channels, GAG-degrading enzymes, and protein glycosylation may be useful targets for suppression of metastasis.

AB - Cancer metastasis is regulated by many factors. In this review article, we introduce novel molecular targets for the suppression of cancer metastasis. Dehydroxymethylepoxyquinomicin (DHMEQ) is a specific inhibitor of NF-κB that inhibits many types of cancer cell growth in vivo. Recently, DHMEQ was reported to suppress cell invasion in an ovarian cancer cell line due to the deregulation of the autocrine system of CXCL12/ CXCR4. An ATP-sensitive K + channel blocker, glybenclamide, has been reported to suppress PDGF secretion, thereby inhibiting cell migration in ovarian cancer. Other emerging molecular targets are glycosaminoglycan (GAG)-degrading enzymes, such as heparanase and hyaluronidases. These inhibitors have been shown to suppress cancer cell metastasis both in vitro and in vivo. We previously reported the important role of protein glycosylation for metastasis-related protein functions. Thus, we hypothesize that NF-κB, K+ channels, GAG-degrading enzymes, and protein glycosylation may be useful targets for suppression of metastasis.

KW - CXCL12/CXCR4

KW - Glycosylation

KW - Heparanase

KW - Invasion

KW - K channel

KW - Metastasis

KW - Migration

KW - Molecular target

KW - Nuclear factor κB (NF-κB)

UR - http://www.scopus.com/inward/record.url?scp=84885014869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885014869&partnerID=8YFLogxK

U2 - 10.1615/ForumImmunDisTher.2013008306

DO - 10.1615/ForumImmunDisTher.2013008306

M3 - Article

AN - SCOPUS:84885014869

VL - 4

SP - 43

EP - 51

JO - Forum on Immunopathological Diseases and Therapeutics

JF - Forum on Immunopathological Diseases and Therapeutics

SN - 2151-8017

IS - 1

ER -